Conventional tumor markers, such as carcinoembryonic antigen (CEA), carbohydrate antigen (CA) 19-9, and squamous cell carcinoma antigen (SCC), have been used in diagnostic assays for early detection and monitoring the tumor dynamics of EC. This evidence concerns the gene CEACAM5 and neoplasm.